This review explores the correlation and heterogeneity of FGF23 expression in AKI, CKD, and ADPKD, highlighting shared and divergent mechanisms and the diagnostic and therapeutic implications. Here, FGF23 is linked to autosomal dominant polycystic kidney disease.